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ABSTRACT

Insulin resistance and obesity are two conditions associated with hypertension. Although
the causes of hypertension are likely to be multifactorial, dysregulation of renal distal
tubule sodium reabsorption may play a role. It has been shown that insulin increases
sodium reabsorption in the distal tubule through the increased expression of epithelial
sodium channels (ENaC); and obesity has been shown to cause insulin resistance in
various tissues. Thiazolidinediones (TZDs) are insulin-sensitizing drugs whose use can
be limited by a side effect of fluid-retention leading to edema and congestive heart
failure. We set out to determine if the expression of ENaC in distal tubule cells, as
modeled by the A6 (frog nephron) cells, became resistant to insulin following exposure to
various concentrations of free-fatty acids (FFAs). We then set out to determine if TZDs
had an insulin-sensitizing effect on distal tubule cells in both a FFA naive environment
and after being exposed to FFAs. We exposed monolayers of A6 nephron cells to
palmitic acid (PA) in concentrations of 0, 0.25, 0.5, 1, and 1.5 mM. After an incubation
time of 20 hours we stimulated the cells with insulin. Measuring the cells with equivalent
short-circuit current we found that as the PA concentration increased from 0 to 0.5 mM
there was an increase in current (Isc), implying an increase in ENaC activity, followed by
a marked decrease in Isc at PA concentrations of 1 mM or greater. Consistent with an
increase in Isc, the calculated transepithelial resistance decreased with 0.25 and 0.5 mM
PA, however, at higher concentrations of PA we observed a marked drop in resistance,
implying probable apoptosis. After insulin treatment we found that in control cells (0
mM PA) the Isc increased 100% whereas with increasing concentrations of PA, there was

a smaller fractional increase of 46%, 12% and 0% at 0.25, 0.5 and 1.0 mM PA,
respectively. After verifying that PPARα, β, and γ were expressed in these cells we
treated A6 cells with 10 μM of Rosiglitazone (PPARg agonist) or 3 mM of Clofibrate
(PPARa agonist). We found there was no change in Isc following exposure to these
drugs. We next pretreated the cells with both 0.5 mM PA with Clofibrate or
Rosiglitazone. Again, there was no statistically-significant difference between these
conditions.

Overall we found that exposure to PA caused resistance to the insulin

induced ENaC expression in A6 cells; at small concentrations of PA there was increased
base-line ENaC expression but higher concentrations were toxic to the cells. We also
found that TZDs did not have any effect on ENaC expression at base-line, with insulin, or
with exposure to PA.

INTRODUCTION

ENaC

Epithelial Na+ channels (ENaC) are located on the apical face of many sodium-absorbing
epithelia. They facilitate the passive transport of Na+ into these cells as the initial step in
transporting the Na+ through the epithelia.

The passive transport is driven by the

Na+/K+-ATPase located on the basolateral side of the cells ({{175 Garty,H. 1997; }}).
ENaC is composed of three homologous subunits: α, β, and γ; and is a tetrameric channel
with an α2βγ stoichiometry ({{176 Kosari,F. 1998; }}). Regulation of ENaC can be
achieved, pharmacologically, with amiloride, which blocks the channel completely; and,
depending on the tissue, ENaC activity can be increased with the hormones aldosterone,
vasopressin, or insulin.

ENaC is found in a wide variety of epithelial cells: the kidney, bladder, intestines, sweat
and salivary glands, lung, taste cells, mechanosensory cells, and in amphibian skin among
others.

Though the physiologic purpose of ENaC varies from tissue to tissue, the

function of the channel remains the same: passive absorption of Na+.

ENaC in the distal convoluted tubule
The kidney plays a crucial role in fluid and electrolyte homeostasis. Total body Na+
concentration is the main determinant of extra-cellular fluid volume. The filtered load of
Na+ in human kidneys is approximately 25,500 mmole/day, or 1.5 kg of table salt or

about 9 times the total amount of Na+ present in the body{{178 Boron, Walter F. 2003;
}}; therefore, since the kidney filters the entire vascular fluid many times a day, it is
crucial that almost all the Na+ is reabsorbed.

65% of the filtered sodium load is

reabsorbed in the proximal tubule, 25% is reabsorbed in the thick ascending limb, and the
remaining 10% is reabsorbed distal to the macula densa. This distal portion of the
nephron is broken down into the distal convoluted tubule, the cortical collecting tubule,
and the medullary collecting duct. The principal cells of the cortical collecting tubule
and collecting duct absorb Na+ via ENaC; and although Na+ absorption in this portion of
the nephron only accounts for around 2-3% of the filtered Na+ load, it is crucial to extracellular fluid volume status. This is illustrated by the results of two disorders that
manifest themselves through dysfunctions of ENaC regulation in the distal tubule.

In Liddle’s syndrome ENaC activity and/or expression is constitutively increased leading
to severe hypertension that is refractory to treatment except from ENaC blockers. In
pseudohypoaldosteronism type 1 a defect in one or more of the ENaC sub-units which
prevents their insertion into the apical cell membrane leads to excess fluid and Na+
excretion in the urine leading to salt wasting, hyperkalaemia, and metabolic acidosis,
despite increased serum aldosterone levels.

Regulation
ENaC activity in the distal tubule is regulated by the renin-angiotensin-aldosterone axis
(RAA), arginine vasopressin (AVP) or anti-diuretic hormone (ADH), insulin, the
sympathetic nervous system, and atrial natriuretic peptide (ANP). RAA, AVP/ADH, and

the sympathetic nervous system increases Na+ retention in response to decreased
vascular pressure. ANP atrial natriuretic peptide increases Na+ excretion in response to
an overly distended right atrium.

Aldosterone acts to increase the transcription,

translation, and number of ENaC channels present on the apical side of the cells which
leads to increased Na+ absorption{{172 Alvarez de la Rosa,D. 2002; }}.

Insulin also increases Na+ retention in both the thick ascending limb and the distal
nephron, particularly the cortical nephron. Similar to aldosterone, insulin increases the
density of ENaC channels present on the apical side of the distal tubule. Though both
hormones increase the number of channels, they act through two different mechanisms
over different time periods; aldosterone induces new protein production and increases
channel density over a period of hours; whereas insulin increases channel density within
minutes. It has been postulated that insulin initiates fusion between the apical cell
membrane and pre-formed intra-cellular vesicles containing ENaC channels. Though
both hormones have the same general effect, they appear to work through independent
mechanisms {{179 Blazer-Yost,B.L. 1998; }}.

ENaC in Xenopus l.: A good model for mammalian dct and ENaC
ENaC is also found in a model renal-like epithelia cell line called A6 derived from the
frog kidney of Xenopus laevis. This cell line provided the cells in which we conducted
our experiments. A6 epithelia are a widely used model for mammalian distal tubule; in a
paper by Shane et al, this A6 cell line was compared to mouse principal cells of the
kidney cortical collecting duct and were shown to have similar responses to aldosterone,

insulin, vasopressin, and amilioride{{177 Shane,M.A. 2006; }}. Other advantages to this
cell line are that it provides homologous ENaC genotypes and phenotypes, and that it is a
single cell type.

INSULIN

Insulin is a secretory protein synthesized in the β cells of the pancreas. In a healthy
individual the secretion of insulin is closely linked to rising blood-glucose levels and is
the major hormone responsible for coordinating the body’s fuel metabolism. Insulin has
profound effects on both carbohydrate and lipid metabolism and significant influence on
protein and mineral metabolism.

Insulin affects many tissues. Generally considered “the well-fed hormone” because of its
increased secretion following food intake, insulin manages the body’s reaction to
absorbed glucose. In the liver, the increased plasma insulin promotes formation of
glycogen from glucose, promotes lipogenisis, the formation of triglycerides, and
decreases the breakdown of glycogen. In both adipose and muscle tissue, insulin acts to
increase the oxidation of carbohydrates as a principle fuel source, while converting the
excess glucose present in the bloodstream into lipids or glycogen. Insulin receptors are
found in many tissues; however Shulman et al showed that muscle plays the greatest role
in insulin and glucose homeostasis and is a thoroughly studied area{{180 Shulman,G.I.
1990; }}. As we already noted, the distal tubule is also sensitive to insulin. Though not a

major factor in glucose homeostasis, insulin acts to increase ENaC expression on the
apical side of the tubule cells.

Insulin resistance and hyper-insulinemia
Though many tissues are sensitive to insulin, some tissue can become resistant to insulin.
Insulin resistance is simply a condition where a given concentration of insulin produces a
less-than-expected biological effect and comprises a broad spectrum of disorders
including diabetes, syndrome X, obesity, and glucose intolerance{{181 Olatunbosun,
S.T.; }}. The significance of these conditions is immense. Type 2 diabetes alone is the
leading cause of blindness among working-age adults, end-stage renal disease, and nontraumatic loss of limb, and the 5th leading cause of death in the U.S.. Financially, the
costs of type 2 diabetes is $92 billion in the U.S. alone {{182 Petersen,K.F. 2006; }}.

The cause of insulin resistance has not been fully elucidated. Once again research into
muscle’s role in insulin/glucose homeostasis gives us the most information on possible
mechanisms. As glucose is taken up from the bloodstream, muscle cells convert the
glucose to glycogen through a series of biochemical steps. It has been shown that insulin
resistance in muscle is attributed to a reduction in insulin-stimulated glucose transport
into the cells and not an induced dysfunction down-stream in the glycogen pathway
{{182 Petersen,K.F. 2006; }}.

One cause of insulin resistance in muscle appears to be intracellular lipid content. It has
been shown that there is a negative correlation between intracellular triglyceride (TG)

content and glycogen synthase activity; it was also shown that there was a positive
correlation between intracellular lipid content and features of insulin resistant syndromes
such as: increased waist to hip ratio, and fasting nonesterified fatty acid levels{{183
Phillips,D.I. 1996; }}. It has also been shown that children of parents with type 2
diabetes are 40% more likely to get it than controls and that the increased concentration
of plasma fatty acids in these individuals is significantly correlated with their insulin
resistance{{184 Perseghin,G. 1997; }}.

Not all the tissue types that are sensitive to insulin become insulin resistant at the same
rate. Some of the problems encountered in insulin resistant states are a result of certain
tissue not becoming resistant to the effects of insulin. For example, in a patient whose
muscle tissue requires a higher concentration of insulin for normal glucose homeostasis,
the hyperinsulinemia acting on the liver, which is not initially as resistant to the effects of
insulin, leads to hypertriglyceridemia; and on the ovary it leads to hyperandrogenism. In
studies of the kidneys, rats, rabbits, and anecdotal evidence concerning humans indicate
that chronic insulin infusion or hyperinsulinemia leads to increased ENaC expression and
Na+ retention in the distal tubule. This increased retention of Na+ and the resultant intravascular volume expansion is one possible etiology of hypertension (HTN) in the
hyperinsulinemic state{{186 Baum,M. 1987; }}{{188 Song,J. 2006; }}.

HYPERTENSION

Hypertension (HTN) in an otherwise healthy adult is defined as a systolic and/or diastolic
arterial pressure greater than 140 and 90 mm Hg respectively. Worldwide the prevalence
of HTN may be as high as 1 billion with approximately 7.1 million deaths attributable to
it each year {{189 Chobanian,A.V. 2003; }}. The World Health Organization estimates
HTN is responsible for 62% of cerebrovascular disease and 49% of ischemic heart
disease and is the number one attributable risk for death in the world{{189
Chobanian,A.V. 2003; }}.

The etiology of hypertension is multifactorial and very

complex. Aspects of the circulating blood volume such as viscosity, vascular reactivity,
humoral mediators, cardiac output, neural stimulation, and others, including increased
sodium retention contribute to HTN.

The Role of ENac in HTN
Since total body sodium determines the extra-cellular fluid volume, pathologic upregulation of sodium re-absorption in the kidney can lead to HTN{{163 Herlitz,H. 1996;
}}.

As sodium intake changes throughout the day, the distal nephron responds by

altering the amount of sodium absorbed from the lumen of the tubule. ENaC inserted in
the apical side of the cells are responsible for this re-absorption{{164 Horisberge, J.D.
1993; }}{{165 Barbry,P. 1997; }}. ENaC expression and activity is up-regulated in
response to low blood pressure, but in a pathologic state ENaC activity can be increased
by various mechanisms, regardless of blood pressure, leading to HTN{{166
Ecelbarger,C.A. 2006; }}.

An extreme example of this pathology is illustrated by

Liddle’s syndrome which is a disease resulting from increased ENaC activity leading to
hypokalemia, metabolic alkalosis, and HTN{{173 Hummler,E. 2003; }}.

Lending

credence to the observation that ENaC is responsible for the HTN in Liddle’s syndrome
is the therapy employed to deal with the disease which consists of amiloride and
triamterene both of which directly block ENaC; and spironolactone, a mineralocorticoid
antagonist, is ineffective at treating this disorder{{190 Botero-Velez,M. 1994; }}.

FREE FATTY ACIDS

Fatty acids are the main source of reserve energy in the body. Most fatty acids are
supplied by the diet but they can also be synthesized de novo from excess carbohydrates
and protein. Fatty acids in the circulation, either bound to albumin or not, are referred to
as ‘free fatty acids’ (FFAs). The normal serum concentration of FFAs is between 200600 μM{{195 Synak,M. 2003; }} and generally consists of a mixture of 6 FFAs:
palmitate (25%), stearate (10%), oleate (38%), linoleate (22%), arachidonate (3%), and
linolenate (2%){{199 Azzazy,H.M. 2006; }}.

Although serum concentrations run

between 200 and 600 μM, FFAs aggregate at concentrations as low as 5-10 μM in an
aqueous solution; therefore almost all free fatty acids are transported in a complex with
albumin. Almost all of the FFAs in serum are transported in this way with <0.01% free
in solution {{196 Richieri,G.V. 1995; }}.

Free-Fatty-Acids and Insulin Resistance
As stated earlier, an elevated serum concentration of FFAs has been shown to be an
independent risk factor for HTN, insulin resistance, and hyperglycemia{{197 Fagot-

Campagna,A. 1998; }}{{198 Griffin,M.E. 1999; }}. FFAs inhibit insulin stimulated
glucose transport in a dose dependent fashion through multiple mechanisms such as:
defects in glucose uptake, defects in proper phosphorylation, and inhibition of glycogen
synthase{{200 Boden,G. 1998; }}. Excess FFAs contribute to hyperglycemia by both
inducing insulin resistance and by increasing hepatic glucose production.

Though

beneficial in the conditions of starvation or pregnancy, FFA induced insulin resistance in
a well-fed state can lead to multiple morbidities.

PPARs

Peroxisome proliferators-activated receptors (PPARs) are ligand-activated transcription
factors and members of the nuclear hormone receptor family. PPARs exist in three
isoforms: PPARα, PPARδ, and PPARγ. PPARs were originally named for their ability to
induce hepatic peroxisome proliferation in mice in response to xenobiotic stimuli {{201
Semple,R.K. 2006; }}. Studies have suggested these receptors are involved in lipid
regulation, metabolism, and nutrient sensing {{201 Semple,R.K. 2006; }}. PPARα binds
to fibrates such as clofibrate and natural ligands such as leukotriene B4 and is a key
regulator of lipid oxidation and has some effects on insulin sensitivity. PPARδ appears to
play a role in fatty-acid controlled differentiation of preadipose cells{{203 Bastie,C.
2000; }}. PPARγ binding with its insulin-sensitizing ligands, thiazolidinediones (TZDs),
lowers glucose levels and FFA levels{{202 Takahashi,S. 2006; }}. Besides the agonist

mentioned specifically for each moiety of PPAR, saturated and unsaturated fatty acids
also act as ligands to this family of receptors{{202 Takahashi,S. 2006; }}.

PPARs and ENaC
It was established that there is a high expression of PPARγ in the inner medullary
collecting ducts of both rabbits and humans, with some expression of PPARα{{204
Guan,Y. 1997; }}. Studies are conflicted concerning the effects of PPARγ activation in
the DCT. They have shown that PPARγ agonists both increase the basal and insulin
stimulated Na+ flux via ENaC in the distal tubule and that PPARγ agonists have no effect
at all{{205 Nofziger,C. 2005;206 Guan,Y. 2005; }}. Since TZDs both increases the
body’s sensitivity to insulin and reduces the serum triglyceride and FFAs levels, they are
increasingly used in the treatment of type 2 diabetes mellitus. However 10-15% of
patients using TZDs are forced to discontinue usage because of dependent edema and
congestive heart failure{{207 King,K.A. 2004; }}. Because these drugs are so effective
in treating type 2 diabetes, it is important to determine the true cause of these side effects
from TZDs.

HYPERTENSION, INSULIN RESISTANCE, FFAs, and THE GOALS
OF OUR STUDY

Hypertension (HTN), insulin resistance, and obesity are three of the core components of
metabolic syndrome{{155 Ford,E.S. 2002; }}. Although criteria defining the syndrome

have changed through the years, these three aspects of the syndrome have been used
consistently to diagnose the disorder. Affecting approximately 22 percent of Americans
with a prevalence increasing to almost 45 percent by the ages of 60-69{{155 Ford,E.S.
2002; }}, the syndrome dramatically raises the risk for many conditions, including: type 2
diabetes, cardiovascular disease{{156 Wong,J. 2006; }}, chronic kidney disease,
cognitive decline, dementia{{157 Roriz-Cruz,M. 2006; }}, and many other pathologic
states.

The link between these three conditions is complex and not fully elucidated. There is
evidence that increased concentrations of free-fatty acids (FFAs) in the blood are toxic to
pancreatic β-cells, leading to type-2 diabetes{{158 Karaskov,E. 2006; }}. There are also
proposed mechanisms in which type-2 diabetes leads to increased FFAs{{161
Garvey,W.T. 2003; }}.

Both conditions can lead to HTN through multiple

pathways{{162 Boden,G. 2006; }}. One of these mechanisms is an alteration of sodium
homeostasis. Since total body sodium determines the extra-cellular fluid volume and
therefore a major component of blood pressure, pathologic up-regulation of sodium reabsorption in the kidney can lead to HTN{{163 Herlitz,H. 1996; }}.

The interplay between insulin resistance, dyslipidemia, and hypertension as seen in
metabolic syndrome led us to investigate two possible etiologies for HTN in insulin
resistant states. As stated earlier, distal tubule cells respond to insulin by increasing
expression of ENaC {{167 Asher,C. 1996; }}and many tissues become insulin resistant
following exposure to increased serum FFAs, but, once again, not all tissues becomes

insulin resistant at the same rate. Therefore, we postulated that if distal tubule cells
remain sensitive to insulin following exposure to FFAs, the increased serum insulin
found in insulin resistance could lead to increased ENaC expression in the distal tubule,
leading to increased Na+ uptake, volume expansion, and finally result in HTN.

Secondly, if distal tubule cells did become insulin resistant following exposure to FFAs,
we set out to determine a possible mechanism for the observed increase in ENaC
expression in dyslipidemic and hyperinsulinemic states. Since some studies claim that
TZD-induced insulin sensitivity can lead to up-regulation of ENaC in the distal tubule
resulting in edema, and possibly HTN, and because FFAs have been shown to be agonists
for PPARs, we compared the response of Xenopus laevis A6 cells exposed to increased
concentrations of the FFA palmitate to the cells same response to various PPAR agonists.
If the mechanism through which pathologic ENaC up-regulation in a diseased state
occurs can be determined it would provide a valuable target for HTN therapy in an
insulin resistant individual.

METHODS

Cell Culture
A6 cells derived from the kidney of Xenopus laevis were provided by Dr. John Hayslett
(Yale University, New Haven, CT)(7 Hayslett,J.P. 1995). Cells were maintained in
amphibian medium in an incubator set at 27oC and with 1.5% CO2. All experiments were
performed with passages between 105 and 115. Cells were expanded on 100 mm plastic
dishes (Corning®). The cells were grown until confluent and then seeded on 6.5 mm
permeable supports (Transwell® polycarbonate membrane with a pore size of 0.4 μm;
Costar). 250 μL of medium was added to the inner well and 800 μL was added to the
outer well. Medium was changed every 4-5 days. Once the cells showed stable current
and voltage, usually 8-10 days after seeding on transwells, the growing medium was
replaced with serum-free medium and aldosterone was added to a final concentration of
100 nM. The cells were then placed back in the incubator to stabilize. After 12 hours the
current and voltage were measured to determine a baseline. At this point we began our
experiments.

Preparing Amphibian Medium
The medium in which the cells were maintained was made by adding 3 packages of
Dulbecco’s Modified Eagle Medium 10g (powder, low glucose, with L-glutamine,
sodium pyruvate, and pyridoxine hydrochloride, without sodium bicarbonate, Gibco BRL
Life Technologies cat. # 31600-034) to 3600 ml of deionized water. 3.85 g NaHCO3 was
added and equilibrated with 1.5% CO2 to attain pH 7.4. 10 ml L-Glutamine (Gibco

200mM – 100x solution, cat. # 25030-081) was then added. Fetal bovine serum (FBS)
(Gibco BRL Life Technologies, cat. #26140-079) was first heat-inactivated for 30
minutes at 56°C and added to be 10% of the final volume in the medium. Penicillin and
streptomycin were added for a concentration of 1% of the final volume.

Fatty Acid
Various concentrations of Palmitic acid (PA) (Sigma-Ultra, cat. # 5585) ethanol,
amphibian medium, and bovine serum albumin (BSA) (American Bioanylytical, cat. #
AB00440) were used for these experiments. A 0.2 M stock solution was prepared by
dissolving PA in ethanol and filtering into a sterile container.

BSA was added to

amphibian medium without FBS to a final concentration of 20%, gently agitated until
dissolved, and filtered into a separate sterile container. PA working solution was added
to the BSA/amphibian medium to prepare concentrations of 0.25, 0.5, 1, and 1.5 mM.
These solutions were agitated at a high rate at 37º using an Environshaker (Lab-line) for
6-8 hours. Aldosterone was added to each solution for a final concentration of 100
nM/ml. Solutions were filtered through 0.2 μm filters and added directly to the cells.

PPAR agonist
When indicated cells were treated with the PPARγ agonist Rosiglitazone (Cayman
Chemical Co., cat. # 71740) to a final concentration of 10 μM or treated with PPARα
agonist Clofibrate (Sigma-Aldrich cat. # 6643) to a final concentration of 3 mM. Twenty
hours after addition of the drugs, measurements of Isc, transepithelial voltage and
resistance were obtained.

Equivalent Short-circuit Current Measurements
After 20-24 hours of exposure to the experimental conditions voltage and current across
confluent monolayers of A6 cells were measured with Ag/AgCl2 electrodes (made at
Yale electronics shop) connected to a DVC-1000 voltage/current-clamp apparatus (World
Precision Instruments). Short circuit current was measured while the transepithelial
voltage was clamped at 0 mV and at –20 mV. Transepithelial resistance was calculated
from the change in current induced by 20 mV change in voltage according to Ohm’s law.

Western Blotting
Following the electrophysiological measurements the medium containing lipids was
aspirated and the filters were washed with PBS. The filters were removed from the
supports and placed in separate microfuge tubes with 30μl of solubilization buffer (in
mM: 100 NaCl, 50 Tris, pH 8.0, and 1% TritonX-100). Nonsoluble material was removed
by centrifugation at 14,000 rpm for 5-10 minutes. The supernatant was recovered and
used in the Western blotting. After separation in 10% SDS-PAGE gels, proteins were
transferred to Immobilon-P membranes (Millipore). Membranes were blocked with 5%
fat free milk in (mM): 100 NaCl, 50 Tris, pH 8.0, and 0.1% Tween. ENaC subunits were
detected by Western blotting with affinity purified anti-xENaC antibodies at 1:8,000
dilution were added and incubated for 1 h on a rocking platform. Actin was detected with
a commercially available antibody (mouse monoclonal antiactin antibody, Chemicon
International). After three washes of 15 min the membranes were incubated with anti–
mouse or anti-rabbit IgG antibodies conjugated to peroxidase (Sigma-Aldrich) at

1:10,000 dilution. After washes the signal was developed with the ECL+ system
(Amersham Pharmacia Biotech).

Immunofluorescence
Cells on filters were fixed with 4% paraformaldehyde fin PBS for 30 min at RT. Cells
were washed in PBS, permeabilized with 1% TritonX-100 for 20 min. Phalloidin
conjugated with Texas red (1:500 dilution) was added to cells for 1 h. Cells were washed
three times for 15 min with PBS. Filters were removed from support with a fine scalpel
and mounted on slides overlay with mounting solution (VectaShield) supplemented with
DAPI. Filters were examined under a fluorescent microscope Axiophot (Zeiss).

Staining with Oil Red O
A stock solution of Oil Red O was prepared from 0.5 g of Oil Red O in 100 mL of
isopropanol. The working solution consisted of 30 mL of the stock solution added to 20
mL distilled water and filtered. Cells on filters were fixed with 4% paraformaldehyde in
PBS for 30 min at RT. Cells were washed in PBS and then rinsed with 60% isopropanol,
then stained with Oil Red O working solution for 15 minutes and rinsed again with 60%
isopropanol. The cells were then lightly stained with haematoxylin for 1 minute and
rinsed with distilled water. Filters were removed from support with a fine scalpel and
mounted on slides overlay with mounting solution (VectaShield) and examined under a
light microscope.

Northern Blot Analysis.
Isolation of RNA. A6 cells were grown on 24 mm diameter filters for 10 days. Cells
were exposed to PA at the indicated concentrations for 20 h. Total RNA was extracted
using RNeasy Mini Kit (Qiagen). Concentration of RNA was calculated by OD
measurement at 260 and 280 nm
Electrophoresis of RNA. 10 µg of RNA in 5.5 µl from each condition was mixed with
5.4 µl 6 M glyoxal, 16 µl of DMSO, 3 µl of 0.1 M sodium phosphate and 4 µl of loading
buffer. The RNA was resolved in 1% agarose gel in 10 mM NaPO4 buffer. RNA was
transferred to nylon membrane (Amersham) by capillary elution on 20 SSC (3 M NaCl;
0.3 M Na-citrate) for 20 h.
Preparation of radioactive probes. 50 ng of DNA corresponding to the coding
sequence of α, β, and γ ENaC subunits and α subunit of the Na/K-ATPase were used
with Random Primed DNA Labeling kit (Roche). For each probe the reaction consisted
of: 25 ng DNA in 9 μl of water denatured by heating at 95oC for 10 min, 3 μl of dNTP
mix minus dCTP, 2 μl of reaction mixture containing random primers, 5 μl of 50 μCi [α32

P]dCTP, and 1 µl of Klenow enzyme. The reactions were incubated at 30oC for 1 h and

stopped by heating at 65oC for 10 min. Unincorporated deoxyribonucleoside
triphosphates were removed with Quick Spin Column, Sephadex G-50.
Hybridization of probes. Prior to hybridization RNA was cross-linked to nylon
membrane by UV light 254 nm using Stratalinker and auto crosslink setting. Pre
hybridization consisted of 5 x SSC; 50 % Formamide; 5 x Denhardt's-solution; 1 % SDS;
100 µg/ml heat-denatured sheared salmon sperm DNA. Probes were denatured and
immediately mixed with pre-hybridization solution. Membranes were incubated at 42oC

for 12 h. Membranes were subsequently washed 1 x 15 min with 2 x SSC @ RT followed
by wash with 2 x SSC, 0.1 % SDS @ 65 °C until background was low. Membranes were
covered with saran wrap and exposed to film with intensifying screen at -80°C.
Composition of 100 x Denhardt's-solution (500 ml): 10 g Ficoll 400; 10 g
polyvinylpyrrolidone MW 360000; 10 g BSA fraction V; H2O.

RESULTS

Short-circuit Current Examination of A6 Cells
In order to examine ENaC activity after exposure to free-fatty acids (FFAs) we used cells
derived from the distal tubule of Xenopus laevis (A6). Sodium from the lumen enters the
cell via ENaC driven by a favorable electrochemical potential and exits at the basolateral
side by the Na-K/ATPase. This process generates a current that can be measured using
the method of short-circuit current. Isc is a valid measurement of ENaC activity because
in A6 cells almost 100% of the transepithelial current is generated by sodium transport
through ENaC{{172 Alvarez de la Rosa,D. 2002; }}. Another advantage of A6 cells is
that they form monolayers with tight junctions that exhibit high electrical resistance
thereby changes in resistance can be used to monitor the health of the monolayer.

A6 Cells response to Insulin and Aldosterone
A6 cells respond to insulin and aldosterone by increasing ENaC activity. After exposure
to insulin A6 cells increase ENaC activity; the response is quick acting (~3 min) reaching
a plateau at ~30 min{{172 Alvarez de la Rosa,D. 2002; }}. This time course suggests that
intra-cellular vesicles containing pre-assembled ENaC channels merge with the apical
membrane. Such a mechanism is reminiscent of insulin-stimulated translocation of
GLUT4 in skeletal muscle, a process that is blunted when FFAs are elevated{{31 Yu,C.
2002; }}. For this reason we exposed the cells to insulin at the end of 20 hours of PA
treatment and re-measured Isc 30 min later.

Unlike insulin, aldosterone increases

transcription of ENaC and therefore takes much longer, over 6 hours, to reach a maximal

effect{{172 Alvarez de la Rosa,D. 2002; }}. Since there are more channels available
with aldosterone, the over-all current and voltage increase. It was necessary to have a
large magnitude of Isc in order to detect changes induced by PA.

Growth Mediums
The medium to grow A6 cells had to be modified because these are amphibian-derived
cells that require 190 mOsm. In addition, cells were grown in an incubator set at 29°C
and [CO2] of 1.5% to mimic the conditions of amphibian cells. Cells were bathed in a
serum-rich medium until they showed significant voltage and current resistance, implying
they were both healthy and confluent across the filter. Cells were switched to serum-free
medium for 12 hours before beginning experiments to remove lipids contained in the
serum.

Palmitic Acid
Because it is the one of the most abundant saturated free-fatty acid present in the body we
chose to use palmitic acid for our experiments. We prepared concentrations of 0, 0.25,
0.5, 1, and 1.5 mM PA. The physiologic concentrations of FFAs in a non-diseased state
range from 200 to 600 µM, and from 400 to 2000 µM in insulin resistant states with PA
making up approximately 25% of that total.

From previous trials (not shown) we

determined an optimal time-course to conduct the experiments.

We saw effects

beginning at 6 hrs, but a peak effect at 18-24 hours, so we chose to incubate the cells in
the PA solution for ~20 hours.

Effects of Increasing Concentrations of PA on Current, Voltage, Resistance, and the
Epitheleal Monolayer
Figure 1 illustrates the effects of increasing concentrations of PA on current, voltage, and
resistance. Two separate experiments were performed and the data were normalized to
the values of the control condition, 0 mM PA. The effect of PA exhibits a bi-phasic
pattern. As the PA concentration increased from 0 to 0.5 mM there was an increase in Isc
followed by a marked decrease at concentrations of 1 mM or greater [PA]. Consistent
with an increase in Isc, the calculated transepithelial resistance decreased with 0.25 and
0.5 mM PA; however, at higher concentrations of PA we observed a marked drop in
resistance. This latter effect, together with the significant decrease in Isc and Vt, strongly
suggest that the cells underwent apoptosis. A cardinal feature of apoptosis is
fragmentation of DNA, which can be observed by staining nuclei. Figure 2 shows
monolayers of A6 cells on filters that were fixed and stained with phalloidin conjugated
with Texas red, which specifically binds to polymerized actin, and with DAPI, which
stains DNA. The upper panel shows control cells. Phalloidin delineates the peripheral
cytoskeleton of cells (chicken-wire pattern). The nuclei are intact. The lower panel shows
cells treated with 1 mM PA for 20 h. Polymerized actin is poorly organized, the neat
peripheral distribution is lost and clumps of actin appear throughout the field. The nuclei
are fragmented and pyknotic. These changes are most consistent with the advanced
apoptosis.

Insulin Response in Cells Treated with Palmitic Acid
It has been previously reported that A6 cells respond to insulin by increasing ENaC
activity. The values for current and voltage for all PA concentrations were normalized to
the control value (0 mM PA). The response to insulin was expressed as the fractional
increase after insulin stimulation for each PA concentration. Fig. 3 shows that in control
cells (0 mM PA) the Isc increases 100% whereas with increasing concentrations of PA,
there is a smaller fractional increase, 46%, 12% and 0% at 0.25, 0.5 and 1.0 mM PA,
respectively. The absence of response to insulin with 1 mM is another indication that this
concentration of PA is noxious to the cells.

PPARS
The prevalent notion in the literature is that PPARγ agonists, such as Rosiglitazone,
stimulate ENaC activity in the distal tubule leading to sodium retention. It is therefore
conceivable that the increase in Isc induced by PA, which is an endogenous agonist of
PPARs, could be mediated by these receptors. We first verified that PPARα, δ, and γ
were expressed in A6 cells. RT-PCR was conducted using RNA extracted from the cells
and specific primers for each of the PPAR DNA sequences as seen in figure 4. To test
this hypothesis, we treated cells with either Clofibrate, an agonist of PPARα, or
Rosiglitazone, an agonist of PPARγ. In previous experiments we showed that in A6 cells
ENaC does not respond to these drugs. We next pretreated cells with both 0.5 mM PA
and clofibrate or rosiglitazone. Fig. 6 shows there is no statistically-significant difference
between the conditions. From these results it is unlikely that PPARs are the mechanism
through which PA is inducing ENAC expression.

Western Blot Analysis
ENaC is composed of three subunits α, β, and µ. The Western blot, shown in Figure 7,
shows an increased signal for each of the subunits at 0.25 mM and 0.5 mM. This trend
parallels the pattern seen in Figure 1. Western blot signals are determined by the quantity
of the protein present. To verify we had collected a similar amount of cells in each
sample we measured the Na/K ATPase protein as well as the actin, both of which should
be expressed equally throughout the samples.

These results reinforced our earlier

observations from the short-circuit current measurements that PA at certain
concentrations increases the abundance of ENaC proteins and that at higher
concentrations appears to severely damage the cells.

Visualizing the Mononlayer with Oil Red O
When lipids are incorporated into cells there are three possible pathways they enter: 1)
they can be oxidized for energy in the mitochondria; 2) they can be conjugated to
glycerol and stored as triglycerides; 3) or, they can be incorporated into the membranes
as phospholipids. When lipids enter the triglyceride pathway, the lipid is neutralized and
stored in droplets within the cell. Not all cells are capable of storing triglycerides in this
way. To determine possible mechanisms for cellular damage, we stained the cells with
Oil red O (ORO).

ORO is used to show droplets of triglycerides stored in cells. Figure

8 shows a staining of A6 cells treated with 1 mM PA.

There are no obvious

accumulations of triglycerides within the cells and the nuclei are pyknotic, consistent

with apoptosis. The lipids must have entered one of the other two pathways, and caused
significant cellular stress.

DISCUSSION

Type 2 diabetes, metabolic syndrome, and dyslipidemias are issues of great concern for
the medical and public health communities.

In addition to the multiple problems

resulting from these diseases hypertension often accompanies them as a dangerous and
costly co-morbidity.

Although the associations are likely to be multi-factorial, one

possible cause of the hypertension could be fluid over-load from chronic ENaC-mediated
retention of sodium by the kidneys in response to the elevated insulin found in these
states.

Additionally elevated serum FFA levels accompany most hyperinsulinemic

conditions. It is well known that FFA deposits in tissues such as muscle and liver have
been shown to cause insulin resistance in those tissues. TZDs are insulin-sensitizing
drugs whose discovery has been a boon to many type 2 diabetics but unfortunately whose
use is limited by a side effect of fluid-retention leading to edema and congestive heart
failure in up to 15% of patients using them{{227 Mudaliar,S. 2003; }}. In this study we
set out to determine if A6 renal cells became resistant to insulin-induced expression of
ENaC following exposure to increasing concentrations of FFAs and to determine if TZDinduced fluid retention is the result of distal tubular activation of ENaC.

We exposed monolayers of A6 cells to PA in concentrations of 0, 0.25, 0.5, 1, and 1.5
mM for 20 hours, stimulated the cells with insulin, then measured the transepithelial
equivalent short-circuit current. We found that PA had many effects on the renal cells:
stimulation, apoptosis, and insulin resistance.

Unexpectedly we found that

concentrations of 0 to 0.5 mM PA led to a significant increase in baseline current,

implying increased ENaC activity, however, at higher concentrations of PA the current
decreased and eventually dropped to 0 implying probable apoptosis.

As found in

multiple other tissues, stimulation with insulin following PA treatment led to a blunting
of the insulin response for all concentrations of PA.

Although there is some debate the general consensus is that high levels of serum FFAs
lead to insulin resistance in various tissues {{230 Boden,G. 1997; }}{{231 Roden,M.
1996; }}. The mechanism for this resistance is less well understood. In muscle, insulin
activates a tyrosine kinase receptor that leads to tyrosine phosphorylation and,
consequently, to the phosphorylation of other cellular substrates such as the insulin
receptor substrate-1 (IRS-1). Once phosphorylated IRS-1 can then bind PI-3 kinase
which catalyses the proteins necessary for glucose transportation. Reynoso et al found a
dramatic decrease in the phosphorylation levels on both the insulin receptor and the IRS1 in animals treated with PA that could account for the resulting observed insulin
resistance{{232 Reynoso,R. 2003; }}. Though the mechanism for insulin resistance may
be similar in renal cells there is much ground to cover before that assumption can be
made since the pathway for insulin’s effects in distal tubule cells has yet to be elucidated.

Sparangna et al demonstrated that cells treated with PA became apoptotic and
Belosludtsev et al provided a possible mechanism {{233 Belosludtsev,K. 2006; }}{{234
Sparagna,G.C. 2004; }}. They proposed that PA/Ca++ complexes induced pores in the
mitochondrial membrane leading to a drop in mitochondrial membrane potential and
ultimately a release of the pro-apoptotic signal cytochrome c. Eitel et al demonstrated

that FFA-induced apoptosis in human β-cells was substantially reduced when a PKC
inhibitor (U-713122) was used on the cells, indicating another possible mechanism for
FFA-induced apoptosis {{236 Eitel,K. 2003; }}. As with the insulin pathway in renal
cells, the mechanism for PA-induced apoptosis in renal cells is an area of new research
and may follow similar pathways; and if a similar pathway is demonstrated, inhibitors
such as a PKC inhibitor may prove to mitigate damage done to renal cells exposed to
high concentrations of PA.

There are many reports of FFAs acting as both intra-cellular signals and as ligands for
cell-surface receptors. Briscoe et al. found that medium and long chain fatty acids acted
as ligands for G protein-coupled receptors in both the brain and in pancreatic β-cells
{{229 Briscoe,C.P. 2003; }} and it is well established that FFAs act as intracellular
ligands for PPARs. One teleological argument for FFAs acting as ligands is simply that
after ingesting a food-source FFAs would be released into a system and would appear to
be the simplest mechanism for up-regulating certain processes. In the case of FFAs
acting as agonists for ENaC activity in the distal tubule an argument could be made that
in an environment where Na+ is scarce a meal with large amounts of K+ could lead to a
dangerous hyperkalemia and a loss of Na+ if the kidneys didn’t reabsorb the Na+ while
secreting the K+. As stated previously, the principal cells of the distal tubule insert
ENaC channels into the apical cell membrane when stimulated. As Na+ rushes into the
cell from the lumen it diminishes the electrochemical gradient and, coupled with the steep
K+ concentration gradient, K+ is forced into the lumen and excreted with the urine.

We postulated that PA’s effect on distal tubule cells could be mediated by activation of
PPARs as PA has been shown to be an agonist of these proteins in other tissues. TZDs
are a class of drug that, among other actions, increase insulin sensitivity in peripheral
tissue by binding to PPARs. Studies have concluded that TZDs can cause fluid retention,
edema, and congestive heart failure in up to 15% of patients depending on their other
treatment modalities i.e. supplemental insulin injections leads to a higher incidence of
fluid retention and associated co-morbidities{{227 Mudaliar,S. 2003; }},{{228 Guan,Y.
2005; }},{{207 King,K.A. 2004; }}. We proposed that ENaC stimulation in distal tubule
renal cells following exposure to TZDs could be the cause of the excess fluid retention.
There is disagreement in the literature concerning this point with Guan et al showing
activation of ENaC channels following TZD treatment and Nofiziger et al unable to
reproduce those findings {{205 Nofziger,C. 2005;206 Guan,Y. 2005;

}}.

In our

experiments there was not a correlation between TZD use and increased ENaC activity in
A6 renal cells agreeing with the results of Nofiziger et al {{169 Nofziger,C. 2005; }} and
implying another mechanism for the observed fluid retention.

In summary, we found that exposure to high-levels of PA increases sodium transport in
renal epithelial cells of the distal tubule thereby contributing to the development of HTN;
and that levels > 0.5 mM can prove toxic to the same cells. We also found that TZDs did
not have an insulin sensitizing effect on ENAC expression in these cells at base line, with
insulin, or with exposure to PA.

FIGURE 1. Effects of increasing concentrations of palmitic acid on current, voltage,
and resistance in the A6 epithelial monolayer. A6 cells grown on filters and pretreated
with 100 nM of aldosterone were exposed to concentrations from 0 mM – 1.5 mM of PA
for twenty hours. Their current, voltage, and resistance were measured using equivalent
short-circuit current. Each bar is the mean of two independent experiments normalized
to the control.

FIGURE 2. A6 cells stained with phalloidin conjugated with Texas red and DAPI
illustrating cellular damage. Following 20 hours exposure to 1 mM palmitic acid, A6
cells were fixed and stained with phalloidin conjugated with Texas red which binds to
polymerized actin and DAPI which stains DNA. The cells were then visualized under
fluorescent microscope. The upper panel shows the control cells (0 mM PA). The lower
panel shows cells exposed to 1 mM PA. The actin is clearly visualized in the first
column as the red staining. The control shows a markedly more organized structure than
the 1 mM stain. Similarly the nuclei (blue) in the DAPI stain are robust in the control
and pyknotic in the the 1 mM sample.

FIGURE 3. Insulin response in cells treated with Palmitic Acid. Cells were treated as in
Figure 1 after which insulin was added to the cultures and currents and voltages were
measured 30 minutes later. The values for all PA concentrations were normalized to the
control value (0 mM PA). Each bar is the mean of two independent experiments
normalized to the control.

Figure 4. RT-PCR illustrating the presence of PPARα, PPARδ/β, and PPARγ in A6 cells.
RT-PCR was conducted using RNA extracted from the study cells and specific primers
for each of the DNA sequences for PPARα, PPARδ/β, and PPARγ.

FIGURE 5. Effects of PPAR agonists on ENaC expression following exposure to 0.5
mM palmitic acid. A6 cells were treated as in figure 1 in concentrations of 0.5 mM PA
and were then exposed to 10 μM of Rosiglitazone (PPARg agonist) or 3 mM of
Clofibrate (PPARa agonist). The currents and voltages were measured using short-circuit
current and the resistance was calculated using Ohm’s law. There was no statistically
significant difference between each of the conditions. Each bar is the mean of two
independent experiments.

FIGURE 6. Western blot for ENaC subunits following PA exposure. A6 cells were
solubilized and ENaC subunits were detected by Western blotting with affinity purified
anti-xENaC antibodies. Actin was detected with mouse anti-actin antibody. Western
blots are shown for each of the three ENaC subunits as well as ATPase and in all five
conditions. The actin in the 0.5 and 1.5 mM concentrations could not be collected due to
technical difficulty.

FIGURE 7. Northern blot of ENaC subunits of A6 cells treated with the indicated
concentrations of PA. Each blot was hybridized with the corresponding ENaC subunit
and actin probes. Graph represents data normalized to actin using a densitometer.

FIGURE 8. Oil Red O stain for lipid deposits in cells. A6 cells were treated with 0 mM
or 1 mM palmitic acid for 20 hours. The filters were stained with Oil Red O; a fat
soluble stain used for staining triglycerides within cells. Filters were also stained with
haematoxylin; a stain used for DNA to visualize the nucleus. Despite the background
noise of the filter picking up the stains, there are no clear lipid droplets within the cells
and the nuclei are pyknotic and damaged in the 1 mM condition.

